• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Combating ‘chemobrain’ with music

Bioengineer by Bioengineer
August 17, 2020
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

University of Cincinnati colleges collaborate to develop app that studies whether music therapy can improve the brain from effects of cancer treatment

IMAGE

Credit: Joe Fuqua/UC Creative + Brand.

Music as medicine has become a more widely adopted concept over the years and considered as complementary therapy for a number of health issues.

However, University of Cincinnati’s Soma Sengupta, MD, PhD, wondered specifically how it could help patients with neurocognitive problems.

Sengupta, an associate professor of neurology at UC, UC Health neuro-oncologist and co-director of the UC Gardner Neuroscience Institute’s Brain Tumor Center, organized a meeting of the minds with experts across disciplines to come up with a solution for one particular problem: “chemobrain.”

“‘Brain fog or ‘chemobrain’ can impact memory, comprehension or speech, and it often lingers, making it difficult to carry out even some of the most basic everyday activities and greatly decreases overall quality of life,” Sengupta says. “I’ve always been interested in music therapy as a treatment modality for patients who have experienced other types of neurotrauma, like stroke, as well as those who are living with Alzheimer’s disease.

“I wanted to extend this option to cancer patients, who are living with neurocognitive issues due to their treatments and who even live with metastatic disease.”

Sengupta teamed up with experts at UC’s College of Design, Architecture, Art, and Planning (DAAP), and specifically Claudia Rebola, PhD, to meld design and technology and create a music app to target this group of patients.

Rebola and her team came up with the Active Receptive Music for Cancer patients (ARMCAN) program, an interactive music therapy app that will be used two ways: 1. A streaming-type music app allowing patients to listen and enjoy music of any genre or 2. A music creation app allowing patients to co-produce new tracks by adding sounds over the main score. In both cases, patients will listen or create for 15 minutes daily. Ten patients, five in each subgroup, will be assessed in the pilot study, which will take place over the course of 18 months.

“Patients will be randomized to be in either the Active Music condition — creating group — or the Receptive Music condition — listening group,” says Sengupta.

Researchers will first study this app for breast cancer patients/survivors, who historically experience a high rate of neurocognitive issues related to treatment. In addition to assessment using neurofunction tests and surveys, participants will also undergo MRI scans, so that researchers can see if and how their brains physically change with use of the app.

“This is a truly unique collaboration,” Sengupta says. “By combining all of our areas of expertise, we might find a tool to help patients with a number of neurocognitive issues that don’t currently have other effective options.”

###

Media Contact
Katie Pence
katie.pence@uc.edu

Original Source

https://www.uc.edu/news/articles/2020/08/n20936132.html

Tags: Breast CancercancerClinical TrialsComputer ScienceDecision-making/Problem SolvingMedicine/HealthMemory/Cognitive ProcessesMental HealthneurobiologyTechnology/Engineering/Computer Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Cannabinoids Show Limited Cancer Symptom Relief Despite High Patient Use, Review Finds

Cannabinoids Show Limited Cancer Symptom Relief Despite High Patient Use, Review Finds

November 17, 2026
Review Evaluates Artificial Intelligence and Computational Pathology in Triple-Negative Breast Cancer

Review Evaluates Artificial Intelligence and Computational Pathology in Triple-Negative Breast Cancer

November 17, 2026

Persistent Lung Infiltrates After Infection Therapy May Signal Pembrolizumab Pneumonitis

November 17, 2026

Chemotherapy and Anlotinib Achieved 17 Months Progression-Free Survival in Rare Sarcoma Case

November 17, 2026
Please login to join discussion

POPULAR NEWS

  • Vitamin A Deficiency Persists in Congolese Children Despite Long-Term Supplementation Efforts

    Vitamin A Deficiency Persists in Congolese Children Despite Long-Term Supplementation Efforts

    29 shares
    Share 12 Tweet 7
  • Veterinarians Identify Twelve Defences to Improve Medication Safety in Sows

    29 shares
    Share 12 Tweet 7
  • Ascending Aorta Shows Marked Elongation Before Dissection Despite Only Moderate Dilatation

    29 shares
    Share 12 Tweet 7
  • Rural Australian Hospital Study Links Insulin and Polypharmacy to Medication Readmissions

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cannabinoids Show Limited Cancer Symptom Relief Despite High Patient Use, Review Finds

Review Evaluates Artificial Intelligence and Computational Pathology in Triple-Negative Breast Cancer

Persistent Lung Infiltrates After Infection Therapy May Signal Pembrolizumab Pneumonitis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.